Council for Innovation Promotion

C4IP Coalition Updates: June 2024

June was a productive month for C4IP! Here’s a roundup of what our Coalition accomplished over the past month. June Highlights: Combating Counterfeit Products Online Weakened IP rights not only put innovators and businesses at risk, they also have dangerous consequences for consumers. This is evidenced by the spread of counterfeit products, which infringe established […]

C4IP Coalition Updates: June 2024 Read More »

Fact Check: Patents Are Not To Blame for High Drug Prices

Like inventors in every sector, drug developers rely on strong patent protections to create new and innovative medicines. However, because of the prices of many drugs, activists frequently blame patents and accuse companies of abusing the patent system with tactics such as “product hopping,” “evergreening,” and “patent thicketing.” This troubling trend continued during the Senate

Fact Check: Patents Are Not To Blame for High Drug Prices Read More »

New Op-Ed from SBE Council President Karen Kerrigan: Patents dramatically improve startup success

Karen Kerrigan, the president and CEO of the Small Business & Entrepreneurship Council, just published an opinion piece in the Buffalo News explaining how the Patent Eligibility Restoration Act and PREVAIL Act would help startups gain venture funding and bring their groundbreaking inventions to market. She illustrates the importance of patents to startup success, with

New Op-Ed from SBE Council President Karen Kerrigan: Patents dramatically improve startup success Read More »

Fact Check: Price Controls Would Not Make Diabetes Treatments More Accessible

Bringing a new therapeutic to market is a challenging and costly endeavor. Strong intellectual property protections, which enable manufacturers to recoup their successful investments into new treatments, are absolutely essential to encouraging innovation. However, activists and government regulators who seek to weaken IP rights often fail to recognize this fundamental reality. One example of this

Fact Check: Price Controls Would Not Make Diabetes Treatments More Accessible Read More »

New Op-Ed from C4IP Co-Chair Andrei Iancu and UC Berkeley Official Mark Cohen: Why Is The US Helping China Undermine Global Innovation?

C4IP Co-Chair and former USPTO Director Andrei Iancu, along with Mark Cohen, the former director of UC Berkeley’s Asia IP Project, recently published an opinion piece in the International Business Times focusing on China’s secretive policy of issuing anti-suit injunctions, which puts innovative American companies at a major disadvantage when fighting patent theft from Chinese

New Op-Ed from C4IP Co-Chair Andrei Iancu and UC Berkeley Official Mark Cohen: Why Is The US Helping China Undermine Global Innovation? Read More »

Scroll to Top